BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 17079667)

  • 1. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation.
    Mastronardi FG; Wood DD; Mei J; Raijmakers R; Tseveleki V; Dosch HM; Probert L; Casaccia-Bonnefil P; Moscarello MA
    J Neurosci; 2006 Nov; 26(44):11387-96. PubMed ID: 17079667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation.
    Bawadekar M; Gendron-Fitzpatrick A; Rebernick R; Shim D; Warner TF; Nicholas AP; Lundblad LK; Thompson PR; Shelef MA
    Arthritis Res Ther; 2016 Jul; 18(1):173. PubMed ID: 27450561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of the N-terminal histone H2A and H3 peptides by peptidylarginine deiminase IV.
    Saiki M; Watase M; Matsubayashi H; Hidaka Y
    Protein Pept Lett; 2009; 16(9):1012-6. PubMed ID: 19508226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization and expression of peptidylarginine deiminase 4 (PAD4) in mammalian oocytes and preimplantation embryos.
    Brahmajosyula M; Miyake M
    Zygote; 2013 Nov; 21(4):314-24. PubMed ID: 22126893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
    Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
    J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidylarginine deiminase 4 and citrullination in health and disease.
    Anzilotti C; Pratesi F; Tommasi C; Migliorini P
    Autoimmun Rev; 2010 Jan; 9(3):158-60. PubMed ID: 19540364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.
    Moscarello MA; Lei H; Mastronardi FG; Winer S; Tsui H; Li Z; Ackerley C; Zhang L; Raijmakers R; Wood DD
    Dis Model Mech; 2013 Mar; 6(2):467-78. PubMed ID: 23118341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system.
    Musse AA; Li Z; Ackerley CA; Bienzle D; Lei H; Poma R; Harauz G; Moscarello MA; Mastronardi FG
    Dis Model Mech; 2008; 1(4-5):229-40. PubMed ID: 19093029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
    Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
    PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis.
    Shelef MA; Sokolove J; Lahey LJ; Wagner CA; Sackmann EK; Warner TF; Wang Y; Beebe DJ; Robinson WH; Huttenlocher A
    Arthritis Rheumatol; 2014 Jun; 66(6):1482-91. PubMed ID: 24497204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation.
    Zhang X; Bolt M; Guertin MJ; Chen W; Zhang S; Cherrington BD; Slade DJ; Dreyton CJ; Subramanian V; Bicker KL; Thompson PR; Mancini MA; Lis JT; Coonrod SA
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13331-6. PubMed ID: 22853951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradation of nuclear CDKN1A.
    Luo X; Chang S; Xiao S; Peng Y; Gao Y; Hu F; Liang J; Xu Y; Du K; Chen Y; Qin J; Meltzer SJ; Deng S; Feng X; Fan X; Hou G; Jin Z; Zhang X
    Neoplasia; 2022 Nov; 33():100835. PubMed ID: 36113195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citrullination of TNF-α by peptidylarginine deiminases reduces its capacity to stimulate the production of inflammatory chemokines.
    Moelants EA; Mortier A; Grauwen K; Ronsse I; Van Damme J; Proost P
    Cytokine; 2013 Jan; 61(1):161-7. PubMed ID: 23075670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role for PADI-mediated histone citrullination in preimplantation development.
    Kan R; Jin M; Subramanian V; Causey CP; Thompson PR; Coonrod SA
    BMC Dev Biol; 2012 Jun; 12():19. PubMed ID: 22712504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
    Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
    J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role for peptidylarginine deiminase 2 (PAD2) in citrullination of canine mammary epithelial cell histones.
    Cherrington BD; Morency E; Struble AM; Coonrod SA; Wakshlag JJ
    PLoS One; 2010 Jul; 5(7):e11768. PubMed ID: 20668670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidylarginine deiminase: a candidate factor in demyelinating disease.
    Moscarello MA; Pritzker L; Mastronardi FG; Wood DD
    J Neurochem; 2002 Apr; 81(2):335-43. PubMed ID: 12064481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation.
    Wang Y; Li M; Stadler S; Correll S; Li P; Wang D; Hayama R; Leonelli L; Han H; Grigoryev SA; Allis CD; Coonrod SA
    J Cell Biol; 2009 Jan; 184(2):205-13. PubMed ID: 19153223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.
    Arita K; Shimizu T; Hashimoto H; Hidaka Y; Yamada M; Sato M
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5291-6. PubMed ID: 16567635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
    Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA
    Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.